Pentavalent Antimonials: New Perspectives for Old Drugs

Molecular Basis of Antimony Treatment in Leishmaniasis†

(2009) Paola Baiocco et al.   JOURNAL OF MEDICINAL CHEMISTRY

Characterization of Sodium Stibogluconate by Online Liquid Separation Cell Technology Monitored by ICPMS and ESMS and Computational Chemistry

(2008) Helle Rüsz Hansen et al.   ANALYTICAL CHEMISTRY

Reduced Tissue Parasitic Load and Infectivity to Sand Flies in Dogs Naturally Infected by Leishmania (Leishmania) chagasi following Treatment with a Liposome Formulation of Meglumine Antimoniate

(2008) R. R. Ribeiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism

(2008) R. Luise Krauth-Siegel et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Interaction of trivalent antimony with a CCHC zinc finger domain: potential relevance to the mechanism of action of antimonial drugs

(2008) Cynthia Demicheli et al.   CHEMICAL COMMUNICATIONS

Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-α production, but only via TNF-α it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro

(2008) Maria Imaculada Muniz-Junqueira et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis

(2008) Eliane de Morais-Teixeira et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Enhanced oral delivery of antimony from meglumine antimoniate/β-cyclodextrin nanoassemblies

(2007) Frédéric Frézard et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate

(2007) Frédéric Frézard et al.   JOURNAL OF INORGANIC BIOCHEMISTRY